Albert D. Mason Inc’s Pfizer PFE Stock Holding History

Albert D. Mason Inc’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,431	Closed	-$384K	–	148
2020 Q4	$384K	Sell	10,431 -563	-5%	-$20.7K	0.27%	116
2020 Q3	$383K	Buy	10,994 +1,253	+13%	+$43.9K	0.31%	112
2020 Q2	$302K	Hold	9,741	–	–	0.25%	120
2020 Q1	$302K	Buy	9,741 +411	+4%	+$14K	0.3%	114
2019 Q4	$347K	Buy	+9,330	New	+$332K	0.25%	125
2019 Q3	–	Sell	-5,609	Closed	-$231K	–	143
2019 Q2	$231K	Sell	5,609 -143	-2%	-$5.68K	0.17%	127
2019 Q1	$232K	Sell	5,752 -489	-8%	-$19.6K	0.17%	127
2018 Q4	$258K	Hold	6,241	–	–	0.21%	123
2018 Q3	$261K	Sell	6,241 -1,096	-15%	-$42.2K	0.18%	123
2018 Q2	$253K	Sell	7,337 -1,512	-17%	-$51.7K	0.18%	125
2018 Q1	$298K	Buy	+8,849	New	+$304K	0.22%	120

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Albert D. Mason Inc's PFE Position: Q1 2021 in Review

Albert D. Mason Inc sold out of Pfizer (PFE) in Q1 2021, closing a stake of 10,431 shares — an estimated $384K sold.

Albert D. Mason Inc first reported a position in PFE in Q1 2018 and held it in 11 quarters. The position peaked at $384K in Q4 2020. 2,675 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

Albert D. Mason Inc reported no remaining Pfizer position as of Q1 2021 after selling out during the quarter.
Albert D. Mason Inc sold 10,431 Pfizer shares in Q1 2021, an estimated $384K.
Albert D. Mason Inc first reported a position in Pfizer in Q1 2018 and held it in 11 quarters.
Albert D. Mason Inc's Pfizer position peaked at $384K in Q4 2020.
2,675 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on Albert D. Mason Inc's 13F filing for Q1 2021, filed 14 Apr 2021.